Press Releases

Hogan Lovells advises MorphoSys on global licensing and development of blood cancer drug tafasitamab

Led by its partners Jörg Schickert and Arne Thiermann, and in close collaboration with MorphoSys in-house deal counsel Virginie Galitschke, international law firm Hogan Lovells has...

Press Releases

Hogan Lovells advised Altavant Sciences in its acquisition of Onspira Therapeutics

New York, 8 January 2020 – International law firm Hogan Lovells advised clinical-stage biopharmaceutical company Altavant Sciences in its acquisition of Onspira Therapeutics, a...

Press Releases

Hogan Lovells advises Vifor Pharma on establishment of joint venture with Evotec for early stage development in nephrology

Led by Munich partner Michael Rose, Hogan Lovells has advised the Swiss pharmaceutical company Vifor Pharma on the establishment of a joint venture with Evotec focusing on the research and...

Blog Post

EMA proposes new pharmacovigilance practices for the paediatric population

The European Medicines Agency (“EMA”) has proposed a new draft guideline document on good pharmacovigilance practices concerning medicinal products used by the paediatric...

Blog Post

EMA's revised guideline on manufacture of the finished dosage form

The European Medicines Agency (EMA) has adopted a new guideline on manufacture of the finished dosage form of medicinal products for human use (“the new Guideline”).

Blog Post

EMA released new procedural guide for Multinational Assessment Teams

The European Medicines Agency (“EMA”) has released a procedural guideline for rapporteurs and coordinators participating in Multinational Assessment Teams (“MNAT”).

Blog Post

The European Commission opens a public consultation concerning EU legislation on Blood and, Tissues and Cells

The European Commission has opened an online stakeholders’ consultation for the evaluation of the European (“EU”) legislation regarding blood and, tissues and cells. The...

Blog Post

EMA further supports Small and medium-sized enterprises (SMEs) with a new Action Plan

The European Medicines Agency (“EMA”) has sought to support Small and Medium-sized Enterprises (SMEs). As part of this effort, the EMA has launched a new Action Plan to address...

Loading data